Glp-1
Found 4 recent publications
3-4 kilograms less: The simple habit that accelerates weight loss
While many struggle with weight-loss medications, a new study reveals that there is a much easier method that can easily shed excess kilograms from the body. The mechanism is not a "fat-burning" magic, but a combination of caloric savings and a slight, temporary increase in energy expenditure.
Bank of America CEO revealed: spending more than $250 million a year on weight-loss drugs for employees
Bank of America spends over $250 million annually to fund GLP-1 weight-loss medications for its staff. CEO Brian Moynihan views the expenditure as a valuable investment in employee health and well-being.
On the way to another revolution: weight-loss injections may reduce breast cancer recurrence
New studies raise the possibility that drugs from the GLP-1 family, used to treat obesity and diabetes, may reduce the risk of breast cancer recurrence. However, at this stage, these are observational findings only.
Planning a pregnancy? New guidelines on weight loss medications
The use of weight loss medications like Ozempic, Wegovy, and Mounjaro raises questions for women of reproductive age. A new international consensus document published in Obesity Reviews provides the first practical guidelines for patients and doctors.